Back

Clinical predictors of very low defibrillation threshold in the extravascular ICD

16 April 2023 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Device Therapy - ICD Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Francis D Murgatroyd

King's College Hospital, London (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
Doctor T. Kleemann (Ludwigshafen, DE)
Abstract Slides
Presentation thumbnail
Automatic subcutaneous defibrillator screening in patients with intracardiac devices: comparative study depending on the point of pacing
Doctor E. Cabrera Borrego (Granada, ES)
Abstract Slides
Presentation thumbnail
A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous icd implantation.
Doctor C. Lopez Perales (Zaragoza, ES)
Abstract Slides
Presentation thumbnail
Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up
Ms J. De Veld (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
The last shall be the first: the role of combined QLV- and CMR-determined electromechanical concordance in predicting optimal left ventricular stimulation site in cardiac resynchronisation therapy.
Doctor M. Bertelli (Bologna, IT)
Abstract Slides

Access the full session

Session thumbnail
Device Therapy - ICD

The Event

Event poster

EHRA 2023

16 April - 18 April 2023
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources